COLUMVI

Concentrate for solution for infusion, 2.5mg
RxActive license

Active substance (INN)

glofitamab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength2.5mg
PackagingUkupno 1 bočica staklena sa 2.5ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FX28)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateDecember 17, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

COLUMVIRx
Concentrate for solution for infusion, 10mgF. Hoffmann-La Roche AG
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026